Literature DB >> 19637806

[Successful treatment of Legionella pneumonia with moxifloxacin in a hemodialysis patient].

Osamu Takakuwa1, Toshinobu Yamamoto, Atsuro Kawai, Masayoshi Torii, Atsushi Nakamura.   

Abstract

Moxifloxacin, a recent, new quinolone agent, has superior pharmacokinetics and appears to be safe for patients with renal failure, as it is mainly excreted in the bile. The case of a hemodialysis patient with Legionella pneumonia who was successfully treated with moxifloxacin is reported. A 76-year-old woman, who had been on hemodialysis for chronic renal failure secondary to diabetic nephropathy, visited her hospital with a cough and fever. Pneumonia was diagnosed, and intravenous administration of cefotiam hydrochloride was begun, but her respiratory condition deteriorated. She was transferred to our hospital with dyspnea. A chest radiograph showed consolidation in both lung fields and cardiomegaly. A urinary antigen test for Legionella was positive. Legionella pneumonia with heart failure was diagnosed and she was started on 400 mg a day moxifloxacin. Her clinical condition improved. Moxifloxacin appears to be useful in the treatment of Legionella pneumonia in patients with renal failure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19637806

Source DB:  PubMed          Journal:  Nihon Kokyuki Gakkai Zasshi        ISSN: 1343-3490


  1 in total

1.  Fatal Fulminant Legionnaires' Disease in a Patient on Maintenance Hemodialysis.

Authors:  Akira Kawashima; Daisuke Katagiri; Isao Kondo; Emi Sakamoto; Minami Suzuki; Yohei Arai; Fumie Sato; Manami Tada; Fumihiko Hinoshita
Journal:  Intern Med       Date:  2020-04-23       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.